On March 6, 2018 Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that Pieris will present at the following upcoming investor conferences (Press release, Pieris Pharmaceuticals, MAR 6, 2018, View Source [SID1234524460]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cowen & Company 38th Annual Health Care Conference, Tuesday, March 13, 2018 at 8:40 a.m. EDT at the Marriott Copley Place in Boston. A webcast of the presentation can be accessed by visiting this link.
The Oppenheimer & Co. 28th Annual Healthcare Conference, Tuesday, March 20, 2018 at 11:30 a.m. EDT at the Westin New York Grand Central in New York City. A webcast of the presentation can be accessed by visiting this link.